Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

26.09.2022

9 Ann Intern Med
1 Antiviral Res
1 Biochemistry
1 BMC Pediatr
11 BMJ
2 Cell
1 Drug Saf
2 Epidemiol Infect
3 J Clin Microbiol
2 J Exp Med
7 J Infect Dis
2 J Virol
2 J Virol Methods
6 JAMA
2 MMWR Morb Mortal Wkly Rep
2 N Engl J Med
1 PLoS Biol
2 PLoS Comput Biol
50 PLoS One
2 Proc Natl Acad Sci U S A
8 Vaccine
4 Virology
1 Virus Res



    Ann Intern Med

  1. AGARWAL A, Martin GS
    In COVID-19 acute hypoxemia, awake prone positioning vs. usual care did not reduce intubation at 30 d.
    Ann Intern Med. 2022 Sep 6. doi: 10.7326/J22-0068.
    >> Share

  2. BOTTON J, Jabagi MJ, Bertrand M, Baricault B, et al
    Risk for Myocardial Infarction, Stroke, and Pulmonary Embolism Following COVID-19 Vaccines in Adults Younger Than 75 Years in France.
    Ann Intern Med. 2022 Aug 23. doi: 10.7326/M22-0988.
    >> Share

  3. BAKER JV, Lane HC
    The Fast and the Furious: Chasing a Clinical Niche for COVID-19 Convalescent Plasma.
    Ann Intern Med. 2022 Aug 16. doi: 10.7326/M22-2329.
    >> Share

  4. ESTCOURT LJ, Cohn CS, Pagano MB, Iannizzi C, et al
    Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma.
    Ann Intern Med. 2022 Aug 16. doi: 10.7326/M22-1079.
    >> Share


  5. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
    Ann Intern Med. 2022 Aug 9. doi: 10.7326/M22-1503.
    >> Share

  6. SALOMON JA, Bilinski A
    Evaluating the Performance of Centers for Disease Control and Prevention COVID-19 Community Levels as Leading Indicators of COVID-19 Mortality.
    Ann Intern Med. 2022 Aug 2. doi: 10.7326/M22-0803.
    >> Share

  7. CHOU R, Dana T, Jungbauer R
    Update Alert 8: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.
    Ann Intern Med. 2022 Jul 26. doi: 10.7326/L22-0272.
    >> Share

  8. CANTOR AG, Jungbauer RM, Totten AM, Tilden EL, et al
    Telehealth Strategies for the Delivery of Maternal Health Care : A Rapid Review.
    Ann Intern Med. 2022 Jul 26. doi: 10.7326/M22-0737.
    >> Share

  9. FOLLMANN D, Janes HE, Buhule OD, Zhou H, et al
    Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/M22-1300.
    >> Share


    Antiviral Res

  10. CHENG Y, Yang C, Li Z, Li X, et al
    Anti-influenza virus activity of the REV-ERBalpha agonist SR9009 and related analogues.
    Antiviral Res. 2022 Sep 16:105418. doi: 10.1016/j.antiviral.2022.105418.
    >> Share


    Biochemistry

  11. WANG J, Shi Y, Reiss K, Maschietto F, et al
    Structural Insights into Binding of Remdesivir Triphosphate within the Replication-Transcription Complex of SARS-CoV-2.
    Biochemistry. 2022;61:1966-1973.
    >> Share


    BMC Pediatr

  12. CESCA L, Conversano E, Vianello FA, Martelli L, et al
    How Covid-19 changed the epidemiology of febrile urinary tract infections in children in the emergency department during the first outbreak.
    BMC Pediatr. 2022;22:550.
    >> Share


    BMJ

  13. THIAGARAJAN K
    Covid-19: China reopens borders to medical students, but problems remain.
    BMJ. 2022;378:o2280.
    >> Share

  14. OWENS B
    How "long covid" is shedding light on postviral syndromes.
    BMJ. 2022;378:o2188.
    >> Share

  15. KAPOOR C
    Covid-19 sets back progress on neglected diseases in India.
    BMJ. 2022;378:o2181.
    >> Share

  16. PUNTIS J
    Crafted responses to covid belong in national galleries.
    BMJ. 2022;378:o2254.
    >> Share


  17. The needs of patients with long covid must not be ignored.
    BMJ. 2022;378:o2287.
    >> Share

  18. NOPPERT GA, Duchowny KA, Clarke PJ
    Declining US life expectancy since covid-19-structural inequities foreshadow future fallout.
    BMJ. 2022;378:o2249.
    >> Share


  19. Update to living WHO guideline on drugs for covid-19.
    BMJ. 2022;378:o2224.
    >> Share

  20. LOOI MK
    Is covid-19 settling into a pattern?
    BMJ. 2022;378:o2183.
    >> Share

  21. SCHUIT E, Venekamp RP, Hooft L, Veldhuijzen IK, et al
    Diagnostic accuracy of covid-19 rapid antigen tests with unsupervised self-sampling in people with symptoms in the omicron period: cross sectional study.
    BMJ. 2022;378:e071215.
    >> Share

  22. GRIFFIN S
    Covid-19: Commission describes "massive global failures" of pandemic response.
    BMJ. 2022;378:o2237.
    >> Share

  23. WISE J
    Covid-19: WHO urges action as 17 million long covid cases are estimated in Europe.
    BMJ. 2022;378:o2232.
    >> Share


    Cell

  24. ACHARYA D, Reis R, Volcic M, Liu G, et al
    Actin cytoskeleton remodeling primes RIG-I-like receptor activation.
    Cell. 2022;185:3588-3602.
    >> Share

  25. FRANK F, Keen MM, Rao A, Bassit L, et al
    Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.
    Cell. 2022;185:3603-3616.
    >> Share


    Drug Saf

  26. KAUR U, K L A, Chauhan M, Joshi A, et al
    A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis.
    Drug Saf. 2022;45:1099-1109.
    >> Share


    Epidemiol Infect

  27. ZHOU N, Dai H, Zha W, Lv Y, et al
    The impact of meteorological factors and PM2.5 on COVID-19 transmission - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e164.
    >> Share

  28. RICCARDO F, Frisicale EM, Guzzetta G, Ferraro F, et al
    Winning during a pandemic: epidemiology of SARS-CoV-2 during EURO2020 in Italy.
    Epidemiol Infect. 2022;150:e166.
    >> Share


    J Clin Microbiol

  29. DUPONT D, Richard JC, Wallon M, Debord-Peguet S, et al
    Photo Quiz: Oral Finding in a 50-Year-Old Man Hospitalized for COVID-19.
    J Clin Microbiol. 2022;60:e0065922.
    >> Share

  30. DIEM G, Lafon E, Bauer A, Lass-Florl C, et al
    Salivary IgAs and Their Role in Mucosal Neutralization of SARS-CoV-2 Variants of Concern.
    J Clin Microbiol. 2022;60:e0106522.
    >> Share

  31. MITCHELL SL, Loeffelholz MJ
    Considerations regarding Interpretation of Positive SARS-CoV-2 Molecular Results with Late Cycle Threshold Values.
    J Clin Microbiol. 2022;60:e0050122.
    >> Share


    J Exp Med

  32. BEER J, Crotta S, Breithaupt A, Ohnemus A, et al
    Impaired immune response drives age-dependent severity of COVID-19.
    J Exp Med. 2022;219.
    >> Share

  33. ZHANG Q, Pizzorno A, Miorin L, Bastard P, et al
    Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
    J Exp Med. 2022;219.
    >> Share


    J Infect Dis

  34. ASSAWAKOSRI S, Suntronwong N, Yorsaeng R, Kanokudom S, et al
    Breakthrough infection by SARS-CoV-2 Delta and Omicron variants elicited immune response comparable to mRNA booster vaccination.
    J Infect Dis. 2022 Jul 5. pii: 6631219. doi: 10.1093.
    >> Share

  35. REN Z, Sun R, Cui G, Wang H, et al
    Effects of Inactivated Vaccination on Humoral Immune Responses in Patients Infected with Delta or Omicron Variants.
    J Infect Dis. 2022 Jul 5. pii: 6631218. doi: 10.1093.
    >> Share

  36. MWIMANZI F, Lapointe HR, Cheung PK, Sang Y, et al
    Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose.
    J Infect Dis. 2022 May 11. pii: 6583561. doi: 10.1093.
    >> Share

  37. LE GARS M, Sadoff J, Struyf F, Heerwegh D, et al
    Impact of preexisting anti-Ad26 humoral immunity on immunogenicity of the Ad26.COV2.S COVID-19 vaccine.
    J Infect Dis. 2022 Apr 16. pii: 6569363. doi: 10.1093.
    >> Share

  38. BURNETT E, Parashar UD, Winn A, Tate JE, et al
    Trends in rotavirus laboratory detections and internet search volume before and after rotavirus vaccine introduction and in the context of the COVID-19 pandemic-- United States 2000-2021.
    J Infect Dis. 2022 Feb 20. pii: 6532606. doi: 10.1093.
    >> Share

  39. NOH JY, Yang JS, Hwang SY, Hyun H, et al
    Duration of Humoral Immunity and Cross-Neutralizing Activity Against the Alpha, Beta, and Delta Variants After Wild-Type Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Prospective Cohort Study.
    J Infect Dis. 2022;226:975-978.
    >> Share

  40. FEROLLA FM, Yfran EW, Ballerini MG, Caratozzolo A, et al
    Serum Vitamin D Levels and Life-Threatening Respiratory Syncytial Virus Infection in Previously Healthy Infants.
    J Infect Dis. 2022;226:958-966.
    >> Share


    J Virol

  41. GUAN M, Olivier AK, Lu X, Epperson W, et al
    The Sialyl Lewis X Glycan Receptor Facilitates Infection of Subtype H7 Avian Influenza A Viruses.
    J Virol. 2022 Sep 20:e0134422. doi: 10.1128/jvi.01344.
    >> Share

  42. SIA ZR, Chiem K, Huang WC, Seffouh A, et al
    Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus.
    J Virol. 2022 Sep 15:e0100622. doi: 10.1128/jvi.01006.
    >> Share


    J Virol Methods

  43. MOSSCROP L, Watber P, Elliot P, Cooke G, et al
    Evaluation of the impact of pre-analytical conditions on sample stability for the detection of SARS-CoV-2 RNA.
    J Virol Methods. 2022;309:114607.
    >> Share

  44. WANG S, Wu Y, Wang Y, Chen Z, et al
    Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection.
    J Virol Methods. 2022;309:114597.
    >> Share


    JAMA

  45. RUBIN R
    The Dreaded "Twindemic" of Influenza and COVID-19 Has Not Yet Materialized-Might This Be the Year?
    JAMA. 2022 Sep 21. pii: 2796806. doi: 10.1001/jama.2022.15062.
    >> Share

  46. ARABI YM, Aldekhyl S, Al Qahtani S, Al-Dorzi HM, et al
    Effect of Helmet Noninvasive Ventilation vs Usual Respiratory Support on Mortality Among Patients With Acute Hypoxemic Respiratory Failure Due to COVID-19: The HELMET-COVID Randomized Clinical Trial.
    JAMA. 2022;328:1063-1072.
    >> Share

  47. LARKIN HD
    COVID-19 Health Policies and Economies in Nordic Countries.
    JAMA. 2022;328:1029.
    >> Share

  48. RUBIN R
    Despite Its Fan Base, Newly Authorized "Traditional" Novavax COVID-19 Vaccine Is Having Trouble Gaining a Foothold in the US.
    JAMA. 2022 Aug 24. pii: 2795814. doi: 10.1001/jama.2022.13661.
    >> Share

  49. BIRNIE E, Biemond JJ, Appelman B, de Bree GJ, et al
    Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
    JAMA. 2022 Aug 1. pii: 2794999. doi: 10.1001/jama.2022.13854.
    >> Share

  50. MALANI AG, Malani AN
    Preventive Medication for COVID-19 Infection.
    JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.
    >> Share


    MMWR Morb Mortal Wkly Rep

  51. ADJEI S, Hong K, Molinari NM, Bull-Otterson L, et al
    Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1182-1189.
    >> Share

  52. ACCORSI EK, Chochua S, Moline HL, Hall M, et al
    Pediatric Brain Abscesses, Epidural Empyemas, and Subdural Empyemas Associated with Streptococcus Species - United States, January 2016-August 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1169-1173.
    >> Share


    N Engl J Med

  53. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Can Vaccines Prevent Transmission of Covid-19?
    N Engl J Med. 2022;387:e30.
    >> Share

  54. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Developing Mucosal Immunity to Covid-19.
    N Engl J Med. 2022;387:e29.
    >> Share


    PLoS Biol

  55. FERNBACH S, Hale BG
    SARS-CoV-2 takes the bait: Exosomes as endogenous decoys.
    PLoS Biol. 2022;20:e3001787.
    >> Share


    PLoS Comput Biol

  56. OVERTON CE, Pellis L, Stage HB, Scarabel F, et al
    EpiBeds: Data informed modelling of the COVID-19 hospital burden in England.
    PLoS Comput Biol. 2022;18:e1010406.
    >> Share

  57. HILTON J, Riley H, Pellis L, Aziza R, et al
    A computational framework for modelling infectious disease policy based on age and household structure with applications to the COVID-19 pandemic.
    PLoS Comput Biol. 2022;18:e1010390.
    >> Share


    PLoS One

  58. YAKUBU AM, Aryee NA, Bonney EY, Kotey EN, et al
    Molecular characterization of haemagglutinin genes of influenza B viruses circulating in Ghana during 2016 and 2017.
    PLoS One. 2022;17:e0271321.
    >> Share

  59. ARORA M, Dringus S, Bahl D, Rizvi Z, et al
    Engagement of health workers and peer educators from the National Adolescent Health Programme-Rashtriya Kishor Swasthya Karyakram during the COVID-19 pandemic: Findings from a situational analysis.
    PLoS One. 2022;17:e0266758.
    >> Share

  60. FOKAM J, Alteri C, Colagrossi L, Genevieve AM, et al
    Diagnostic performance of molecular and serological tests of SARS-CoV-2 on well-characterised specimens from COVID-19 individuals: The EDCTP "PERFECT-study" protocol (RIA2020EF-3000).
    PLoS One. 2022;17:e0273818.
    >> Share

  61. WITARTO BS, Visuddho V, Witarto AP, Bestari D, et al
    Effectiveness of online mindfulness-based interventions in improving mental health during the COVID-19 pandemic: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0274177.
    >> Share

  62. AGOSTI F, Toffolutti V, Cavalli N, Nivakoski S, et al
    Information and vaccine hesitancy: Evidence from the early stage of the vaccine roll-out in 28 European countries.
    PLoS One. 2022;17:e0273555.
    >> Share

  63. SHEVLIN M, Redican E, Hyland P, Butter S, et al
    Perceived manageability of debt and mental health during the COVID-19 pandemic: A UK population analysis.
    PLoS One. 2022;17:e0274052.
    >> Share

  64. LIMAYE RJ, Balgobin K, Michel A, Schulz G, et al
    What message appeal and messenger are most persuasive for COVID-19 vaccine uptake: Results from a 5-country survey in India, Indonesia, Kenya, Nigeria, and Ukraine.
    PLoS One. 2022;17:e0274966.
    >> Share

  65. GILLEN P, Neill RD, Mallett J, Moriarty J, et al
    Wellbeing and coping of UK nurses, midwives and allied health professionals during COVID-19-a cross-sectional study.
    PLoS One. 2022;17:e0274036.
    >> Share

  66. LUCIEN MAB, Pierre K, Jean-Denis G, Rigodon J, et al
    Epidemiology and risk factors related to severity of clinical manifestations of COVID-19 in outpatients: A retrospective study in Haiti.
    PLoS One. 2022;17:e0274760.
    >> Share

  67. DANG HH, Malesky E, Nguyen CV
    Inequality and support for government responses to COVID-19.
    PLoS One. 2022;17:e0272972.
    >> Share

  68. KAJIWARA SAITO M, Morishima T, Ma C, Koyama S, et al
    Diagnosis and treatment of digestive cancers during COVID-19 in Japan: A Cancer Registry-based Study on the Impact of COVID-19 on Cancer Care in Osaka (CanReCO).
    PLoS One. 2022;17:e0274918.
    >> Share

  69. PAEZ-FRANCO JC, Maravillas-Montero JL, Mejia-Dominguez NR, Torres-Ruiz J, et al
    Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology.
    PLoS One. 2022;17:e0274910.
    >> Share

  70. SANTANA-E-SILVA JJ, Cribari-Neto F, Vasconcellos KLP
    Beta distribution misspecification tests with application to Covid-19 mortality rates in the United States.
    PLoS One. 2022;17:e0274781.
    >> Share

  71. MEAD LB, Mathison T, Osborne G, Richards AM, et al
    Decontamination of Geobacillus Stearothermophilus using the Arca Aerosolized Hydrogen Peroxide decontamination system.
    PLoS One. 2022;17:e0273937.
    >> Share

  72. DE ALMEIDA MB, Aharonov-Nadborny R, Gabbai E, Palka AP, et al
    Clinical trial and detection of SARS-CoV-2 by a commercial breath analysis test based on Terahertz technology.
    PLoS One. 2022;17:e0273506.
    >> Share

  73. DIARRA M, Barry A, Dia N, Diop M, et al
    First wave COVID-19 pandemic in Senegal: Epidemiological and clinical characteristics.
    PLoS One. 2022;17:e0274783.
    >> Share

  74. WU H, Xue M, Wu C, Lu Q, et al
    Trend of hand, foot, and mouth disease from 2010 to 2021 and estimation of the reduction in enterovirus 71 infection after vaccine use in Zhejiang Province, China.
    PLoS One. 2022;17:e0274421.
    >> Share

  75. MISTRY SK, Ali ARMM, Yadav UN, Das Gupta R, et al
    A tale of osteoarthritis among older adults during the COVID-19 pandemic in Bangladesh: A repeated cross-sectional study.
    PLoS One. 2022;17:e0274838.
    >> Share

  76. LIM HM, Ng CJ, Wharrad H, Lee YK, et al
    Knowledge transfer of eLearning objects: Lessons learned from an intercontinental capacity building project.
    PLoS One. 2022;17:e0274771.
    >> Share

  77. LEDESMA JR, Lurie P, Yorlets RR, Daly G, et al
    Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19.
    PLoS One. 2022;17:e0274900.
    >> Share

  78. WASSIF GO, El Din DAG
    Relationship between knowledge, attitude, and practice of COVID-19 precautionary measures and the frequency of infection among medical students at an Egyptian University.
    PLoS One. 2022;17:e0274473.
    >> Share

  79. LAING L, Salema NE, Jeffries M, Shamsuddin A, et al
    Understanding factors influencing uptake and sustainable use of the PINCER intervention at scale: A qualitative evaluation using Normalisation Process Theory.
    PLoS One. 2022;17:e0274560.
    >> Share

  80. VALDERRAMA-BELTRAN SL, Cuervo-Rojas J, Ariza B, Cardozo C, et al
    Cumulative incidence, prevalence, seroconversion, and associated factors for SARS-CoV-2 infection among healthcare workers of a University Hospital in Bogota, Colombia.
    PLoS One. 2022;17:e0274484.
    >> Share

  81. FRAUCHES TS, Costa CAS, Rodrigues CDS, de Azevedo MCVM, et al
    COVID-19 cross-sectional study in Marica, Brazil: The impact of vaccination coverage on viral incidence.
    PLoS One. 2022;17:e0269011.
    >> Share

  82. AN X, Zhang M, Xu S
    An active learning-based approach for screening scholarly articles about the origins of SARS-CoV-2.
    PLoS One. 2022;17:e0273725.
    >> Share

  83. DOMINGUEZ-ESPINOSA ADC, Montes de Oca-Mayagoitia SI, Saez-Jimenez AP, de la Fuente-Zepeda J, et al
    The moderating role of sociodemographic and work-related variables in burnout and mental health levels of Mexican medical residents.
    PLoS One. 2022;17:e0274322.
    >> Share

  84. VIPLER B, Snyder B, McCall-Hosenfeld J, Haidet P, et al
    Transformative learning of medical trainees during the COVID-19 pandemic: A mixed methods study.
    PLoS One. 2022;17:e0274683.
    >> Share

  85. DENG Y, Park M, Chen J, Yang J, et al
    Emotional discourse analysis of COVID-19 patients and their mental health: A text mining study.
    PLoS One. 2022;17:e0274247.
    >> Share

  86. HE Y, Chen Y, Yang L, Zhou Y, et al
    The impact of multi-level interventions on the second-wave SARS-CoV-2 transmission in China.
    PLoS One. 2022;17:e0274590.
    >> Share

  87. LEE L, Valmond L, Thomas J, Kim A, et al
    Wastewater surveillance in smaller college communities may aid future public health initiatives.
    PLoS One. 2022;17:e0270385.
    >> Share

  88. SABIKUNNAHAR B, Lahue KG, Asarian L, Fang Q, et al
    Sex differences in susceptibility to influenza A virus infection depend on host genotype.
    PLoS One. 2022;17:e0273050.
    >> Share

  89. VISCONTI-LOPEZ FJ, Hernandez-Vasquez A, Solorzano-Salazar DM, Azanedo D, et al
    Chronic disease relapses: A cross-sectional study of the associated factors and socioeconomic inequalities during the COVID-19 pandemic in Peru.
    PLoS One. 2022;17:e0274697.
    >> Share

  90. HAGGLUND S, Naslund K, Svensson A, Lefverman C, et al
    Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age.
    PLoS One. 2022;17:e0274332.
    >> Share

  91. PERROT JC, Segura M, Beranuy M, Gich I, et al
    Comparison of post-COVID symptoms in patients with different severity profiles of the acute disease visited at a rehabilitation unit.
    PLoS One. 2022;17:e0274520.
    >> Share

  92. ARSENOVIC S, Trajkovic G, Pekmezovic T, Gazibara T, et al
    Validity of the Health Belief Model Applied to Influenza among people with chronic diseases: Is it time to develop a new knowledge domain?
    PLoS One. 2022;17:e0274739.
    >> Share

  93. HASAN MM, Murtaz SB, Islam MU, Sadeq MJ, et al
    Robust and efficient COVID-19 detection techniques: A machine learning approach.
    PLoS One. 2022;17:e0274538.
    >> Share

  94. SERETI I, Shaw-Saliba K, Dodd LE, Dewar RL, et al
    Design of an observational multi-country cohort study to assess immunogenicity of multiple vaccine platforms (InVITE).
    PLoS One. 2022;17:e0273914.
    >> Share

  95. KOVACS LN, Katzinger E, Yi S, Demetrovics Z, et al
    Emotion-focused coping mediates the relationship between COVID-related distress and compulsive buying.
    PLoS One. 2022;17:e0274458.
    >> Share

  96. ATKESON LR, Hansen WL, Oliver MT, Maestas CD, et al
    Should I vote-by-mail or in person? The impact of COVID-19 risk factors and partisanship on vote mode decisions in the 2020 presidential election.
    PLoS One. 2022;17:e0274357.
    >> Share

  97. AUGUSTINE J, Hourani K, Molla AR, Pandurangan G, et al
    Scheduling mechanisms to control the spread of COVID-19.
    PLoS One. 2022;17:e0272739.
    >> Share

  98. LO A, Pifarre I Arolas H, Renshon J, Liang S, et al
    The polarization of politics and public opinion and their effects on racial inequality in COVID mortality.
    PLoS One. 2022;17:e0274580.
    >> Share

  99. E SAMADI M, Kiefer S, Fritsch SJ, Bickenbach J, et al
    A training strategy for hybrid models to break the curse of dimensionality.
    PLoS One. 2022;17:e0274569.
    >> Share

  100. TAKEI S, Ai T, Yamamoto T, Igawa G, et al
    Performance evaluation of the Roche Elecsys(R) Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment.
    PLoS One. 2022;17:e0274181.
    >> Share

  101. JANSSON MK, Yamamoto S
    The effect of temperature, humidity, precipitation and cloud coverage on the risk of COVID-19 infection in temperate regions of the USA-A case-crossover study.
    PLoS One. 2022;17:e0273511.
    >> Share

  102. MAHMUD R, Joy KMNI, Rassel MA, Monayem FB, et al
    Health hazards related to using masks and/or personal protective equipment among physicians working in public hospitals in Dhaka: A cross-sectional study.
    PLoS One. 2022;17:e0274169.
    >> Share

  103. RISTAU P, Wnent J, Grasner JT, Fischer M, et al
    Impact of COVID-19 on out-of-hospital cardiac arrest: A registry-based cohort-study from the German Resuscitation Registry.
    PLoS One. 2022;17:e0274314.
    >> Share

  104. CASSIDY C, Sim M, Somerville M, Crowther D, et al
    Using a learning health system framework to examine COVID-19 pandemic planning and response at a Canadian Health Centre.
    PLoS One. 2022;17:e0273149.
    >> Share

  105. GENARI J, Goedert GT, Lira SHA, Oliveira K, et al
    Quantifying protocols for safe school activities.
    PLoS One. 2022;17:e0273425.
    >> Share

  106. P K, T M, T F, M M, et al
    Lucid dreaming increased during the COVID-19 pandemic: An online survey.
    PLoS One. 2022;17:e0273281.
    >> Share

  107. ZARN KE, Jaramillo SA, Zapata AR, Stone NE, et al
    Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants.
    PLoS One. 2022;17:e0272916.
    >> Share


    Proc Natl Acad Sci U S A

  108. ASCHMANN HE, Riley AR, Chen R, Chen YH, et al
    Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2210941119.
    >> Share

  109. YANG K, Wang C, Kreutzberger AJB, Ojha R, et al
    Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein.
    Proc Natl Acad Sci U S A. 2022;119:e2210990119.
    >> Share


    Vaccine

  110. GRAAF A, Petric PP, Sehl-Ewert J, Henritzi D, et al
    Cold-passaged isolates and bat-swine influenza a chimeric viruses as modified live-attenuated vaccines against influenza a viruses in pigs.
    Vaccine. 2022 Sep 19. pii: S0264-410X(22)01108.
    >> Share

  111. WILLIAMS E, Colson J, Valiathan R, Carreno JM, et al
    Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2.
    Vaccine. 2022;40:5868-5872.
    >> Share

  112. MOK CC, Chan KL, Tse SM
    Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosus.
    Vaccine. 2022 Sep 6. pii: S0264-410X(22)01067.
    >> Share

  113. LUBIS TA, Gunardi H, Herqutanto, Soedjatmiko S, et al
    Educational videos to address vaccine hesitancy in childhood immunization.
    Vaccine. 2022 Sep 6. pii: S0264-410X(22)01035.
    >> Share

  114. OKUYAMA M, Morino S, Tanaka K, Nakamura-Miwa H, et al
    Vasovagal reactions after COVID-19 vaccination in Japan.
    Vaccine. 2022 Aug 25. pii: S0264-410X(22)01046.
    >> Share

  115. SANCHEZ-SAEZ F, Peiro S, Cuenca L, Vanaclocha H, et al
    Side effects during the week after first dose vaccination with four Covid-19 vaccines. Results of the ProVaVac Survey Study with 13,837 people in Spain.
    Vaccine. 2022 Aug 29. pii: S0264-410X(22)01007.
    >> Share

  116. ULRICH AK, Pankratz GK, Bohn B, Yendell S, et al
    COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members.
    Vaccine. 2022 Aug 5. pii: S0264-410X(22)00956.
    >> Share

  117. HEMMI T, Ainai A, Hashiguchi T, Tobiume M, et al
    Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Vaccine. 2022 Aug 26. pii: S0264-410X(22)01038.
    >> Share


    Virology

  118. BRAKEL KA, Ma Y, Binjawadagi R, Harder O, et al
    Codon-optimization of the respiratory syncytial virus (RSV) G protein expressed in a vesicular stomatitis virus (VSV) vector improves immune responses in a cotton rat model.
    Virology. 2022;575:101-110.
    >> Share

  119. AMIDEI A, Dobrovolny HM
    Estimation of virus-mediated cell fusion rate of SARS-CoV-2.
    Virology. 2022;575:91-100.
    >> Share

  120. MONTEIRO A, Chang AJ, Welliver RR, Baron S, et al
    Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease.
    Virology. 2022;575:83-90.
    >> Share

  121. POPOVIC M
    Strain wars 4 - Darwinian evolution through Gibbs' glasses: Gibbs energies of binding and growth explain evolution of SARS-CoV-2 from Hu-1 to BA.2.
    Virology. 2022;575:36-42.
    >> Share


    Virus Res

  122. LARBI I, Ghedira K, Marwa A, Butcher GD, et al
    Phylogenetic analysis and assessment of the pathogenic potential of the first H9N2 avian influenza viruses isolated from wild birds and lagoon water in Tunisia.
    Virus Res. 2022 Sep 17:198929. doi: 10.1016/j.virusres.2022.198929.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016